摘要
目的:评价2000～2002年3年间我国医药上市公司并购绩效。方法:以考察26个并购案例中并购公司的财务数据为基础,通过数据包络分析法分析,获得样本公司并购前、后运营效率,从而对其进行比较。结果:运营效率在并购后的前3年有下降趋势,直到第4年才有所改观。结论:并购后未见对公司的运营绩效有提升作用。
OBJECTIVE： To evaluate the performance of merger and acquisition （M＆A） of listed pharmaceutical companies over 3 years from 2000 to 2002. METHODS： Based on the financial data of the listed companies in 26 cases, a data envelopment analysis was performed to compare and evaluate the efficiency of the companies before and after M＆A. RESULTS： The efficiency was reduced in the first 3 years after M＆A, but increased started from the fourth year. CONCLUSIONS： M＆A did not promote the efficiency of listed pharmaceutical companies.
出处
《中国药房》
CAS
CSCD
北大核心
2008年第34期2644-2646,共3页
China Pharmacy
关键词
医药上市公司
并购
数据包络分析
运营效率
绩效
Listed pharmaceutical companies
Merger and acquisition
Data envelopment analysis
Operation efficiency
Performance
